EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HDAC7 promotes ovarian cancer malignancy via AKT / mTOR signalling pathway

Qi Feng, Sheng Hao, Xiongxiu Liu, Zhong Yan, Kai Sheng, Yanping Li, Peng Zhang, Xiugui Sheng iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Qi Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Ovarian Neoplasms, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Program, Shenzhen Healthcare Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is of the most lethal malignancy and causes serious threat to women health worldwide. A deep understanding of molecular mechanisms underlying ovarian cancer progression is critical for the development of promising therapeutic strategies. In this study, we aimed to employ immunohistochemistry to determine the protein level of HDAC7 in patient tissues, our data showed HDAC7 levels are upregulated in tumour tissues. In addition, we also performed Kaplan–Meier survival analysis to investigate the association between HDAC7 expression and clinical prognosis, and found that HDAC7 expression was associated with poor prognosis in ovarian cancer patients. Inhibition of HDAC7 cells resulted in lower cell proliferation, invasion and colony formation. Furthermore, we also found that HDAC7 inhibition suppressed PI3K/AKT/mTOR pathway. In contrast, exogenous HDAC7 expression activated the PI3K/AKT/mTOR pathway in HDAC7 knockout cells and rescued the cell proliferation, invasion and colony formation. However, inhibition of p‐AKT induced lower cell proliferation, metastasis and colony formation abilities. In murine model, HDAC7 KO significantly decreased the tumour burden. These data indicate that HDAC7 is involved in regulation of PI3K/AKT/mTOR pathway and targeting of HDAC7 could be potential therapeutic strategy in the treatment of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesOvarian NeoplasmsProto-Oncogene Proteins c-aktSignal TransductionHistone DeacetylasesCell ProliferationFemaleHumansAnimalsCell Line, TumorMiceGene Expression Regulation, NeoplasticPrognosisPhosphatidylinositol 3-KinasesCell MovementMice, Nude

Stichwörter der Autor:innen

AKTHDAC7histone deacetylasemTORovarian cancer

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktHistone DeacetylasesHDAC7 protein, humanMTOR protein, humanPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Medicine, Jinan University, Guangzhou, China.
  • International Cancer Center, Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Marshall Laboratory of Biomedical Engineering, Department of Biochemistry and Molecular Biology, Shenzhen Univers…
  • Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China.
  • Department of Gynecologic Oncology, Linyi Cancer Hospital, Linyi, China.
  • Shenzhen Maternal and Child Healthcare Hospital, Shenzhen, China.
  • Institute of Precision Medicine, Jining Medical University, Jining, Shandong, China.

ORCID-Profile: Xiugui Sheng

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Healthcare Research Project
  • Sanming Project of Medicine in Shenzen Municipality

Zitieren

APA

Feng, Q., Hao, S., Liu, X., Yan, Z., Sheng, K., Li, Y., Zhang, P., & Sheng, X. (2024). HDAC7 promotes ovarian cancer malignancy via AKT / mTOR signalling pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70120

Vancouver

Feng Q, Hao S, Liu X, Yan Z, Sheng K, Li Y, et al. HDAC7 promotes ovarian cancer malignancy via AKT / mTOR signalling pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70120

BibTeX
@article{Feng2024,
  author = {Feng, Qi and Hao, Sheng and Liu, Xiongxiu and Yan, Zhong and Sheng, Kai and Li, Yanping and Zhang, Peng and Sheng, Xiugui},
  title = {HDAC7 promotes ovarian cancer malignancy via AKT / mTOR signalling pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70120}
}
Kostenlos starten →